Kane Biotech Inc (QB) (KNBIF)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current KNBIF market cap is 10.55M. The company's latest EPS is CAD -0.0400 and P/E is -2.75.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 1.69M | 1.34M | 1.61M | 2.67M | 2.82M |
| Operating Income | -3.59M | -4.23M | -4.88M | -3.36M | -4.09M |
| Net Income | -960k | -3.98M | -4.61M | -3.89M | -5.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.76M | 5.04M | 6.13M | 5.62M | 5.68M |
| Total Liabilities | 1.92M | 3.96M | 7.7M | 9.76M | 14.09M |
| Total Equity | 837k | 1.07M | -1.57M | -4.14M | -8.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -955k | -3.94M | -2.29M | -3.04M | -2.08M |
| Investing | -97k | -166k | -374k | -108k | -115k |
| Financing | 1.81M | 4.28M | 2.81M | 3.1M | 2.98M |
| Market Cap | 10.55M |
| Price to Earnings Ratio | -2.75 |
| Price to Sales Ratio | 5.14 |
| Price to Cash Ratio | 19.3 |
| Price to Book Ratio | -1.72 |
| Dividend Yield | - |
| Shares Outstanding | 131.84M |
| Average Volume (1 week) | 151.56k |
| Average Volume (1 Month) | 55.02k |
| 52 Week Change | 47.47% |
| 52 Week High | 0.12277 |
| 52 Week Low | 0.044 |
| Spread (Intraday) | 100.02 (99.93%) |
| Company Name | Kane Biotech Inc (QB) |
| Address |
290-100 innovation drive winnipeg, manitoba R3T 6G2 |
| Website | https://www.kanebiotech.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
